Silverarc Capital Management, LLC Bridge Bio Pharma, Inc. Transaction History
Silverarc Capital Management, LLC
- $411 Million
- Q1 2025
A detailed history of Silverarc Capital Management, LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Silverarc Capital Management, LLC holds 111,000 shares of BBIO stock, worth $3.67 Million. This represents 0.93% of its overall portfolio holdings.
Number of Shares
111,000Holding current value
$3.67 Million% of portfolio
0.93%Shares
5 transactions
Others Institutions Holding BBIO
# of Institutions
361Shares Held
185MCall Options Held
12.8MPut Options Held
2.09M-
Viking Global Investors LP22.1MShares$730 Million2.55% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY19.3MShares$638 Million30.7% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.9MShares$493 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$412 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X07.17MShares$237 Million0.14% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $4.91B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...